Celldex Therapeutics reported $1.27B in Market Capitalization this January of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 190.63B 8.32B
Agenus AGEN:US $ 1.22B 0B
Amgen AMGN:US $ 120.75B 19.29B
Applied Genetic Technologies AGTC:US $ 0.13B 0.04B
Aptinyx Inc APTX:US $ 0.16B 0.03B
Arena Pharmaceuticals ARNA:US $ 3.64B 0.53B
Biocept BIOC:US $ 0.06B 0B
Bristol Myers Squibb BMY:US $ 131.34B 17.15B
Celldex Therapeutics CLDX:US $ 2.51B 1.18B
Cytrx CYTR:US 0.02B 0.01B
Glaxosmithkline GSK:US 95.15B 3.61B
Immunogen IMGN:US $ 1.18B 0.14B
Merrimack Pharmaceuticals MACK:US $ 0.09B 0.04B
Nektar Therapeutics NKTR:US $ 3.3B 0.17B
Newlink Genetics NLNK:US $ 0.08B 0B
Northwest Biotherapeutics NWBO:US 1.12B 0.14B
Pfizer PFE:US $ 241.14B 21.94B
Rigel Pharmaceuticals RIGL:US $ 0.62B 0.12B
Seattle Genetics SGEN:US $ 30.89B 2.24B